Eliminating HIV: latest progress - Aidsmap

One example is the cancer drug vorinostat, which in one study 1 involving five people produced an up-to-tenfold increase in HIV expression within resting cells, despite their being on HIV treatment, but did not cause HIV to enter the bloodstream.

Seattle Genetics Follows the Science, Taking on Rare Lymphoma No. 3 - Xconomy

There are also more targeted drugs like Eisai Pharmaceuticals’ bexarotene (Targretin), Merck’s vorinostat (Zolinza), or Celgene’s romidepsin (Istodax). But once patients progress past the early rounds of therapy, no treatments have shown ...

Arno AR-42 for neurofibromatosis type 2 receives EMA orphan-drug designation - News-Medical.Net

broad-spectrum deacetylation inhibitor of both histone and non-histone proteins which has demonstrated greater potency and activity in solid tumors and hematological malignancies when compared in preclinical studies to vorinostat (also known as ...

Increased Mammograms Up to 65% Responsible for Breast Cancer Mortality Reduction - msnbc.com

Vinorelbine (Navelbine), Vorinostat (Zolinza) and Zibotentan. For more information, visit: http://www.trimarkpublications.com/game-changers-in-breast-cancer-therapies.

Towards a cure for all: How we might do it - Aidsmap

This may be because valproic acid is not strong enough. Trials are planned of a stronger HDAC inhibitor called vorinostat (Zolinza), a cancer drug already used for some types of lymphoma and which is being trialled for anal cancer. 7 “Vorinostat is a ...

Arno Therapeutics Announces Orphan-Drug Designation for AR-42 in Europe - Yahoo Finance

broad-spectrum deacetylation inhibitor of both histone and non-histone proteins which has demonstrated greater potency and activity in solid tumors and hematological malignancies when compared in preclinical studies to vorinostat (also known as ...